INTRODUCTION
Colorectal cancer (CRC) remains the second leading cause of cancer death in the United States, but recent studies have shown a decrease in CRC mortality that is attributable to screening colonoscopy with polypectomy [1] [2] [3] . A patient's risk of polyp detection during colonoscopy is influenced by age, gender and family history of polyps or CRC, but also by the quality of bowel preparation [4] [5] [6] [7] . Factors that a ect the quality of bowel preparation may also in uence the polyp detection rate (PDR) and thus may play a role in further reducing CRC mortality.
Patient assessment of bowel preparation has been shown to correlate poorly with physician assessment of bowel preparation during colonoscopy [8] [9] . Tolerability of bowel preparation, including physical side e ects, taste and overall acceptability, has been reported as an outcome in studies measuring the effectiveness of bowel preparation [10] . Tolerability of bowel preparation has not been considered as an independent predictor of quality outcomes in colonoscopy, including prep quality and PDR. e aim of this study was to determine whether patient-reported tolerability of bowel preparation plays a predictive role in the achievement of these outcome measures. August 2011, consecutive patients referred for outpatient colonoscopy were o ered participation in the study on the day of colonoscopy by nursing sta not directly involved in the procedure. Patients who agreed to participate in the study provided informed consent prior to enrollment. Neither the referring physician nor the patient was aware of the study until a er the bowel preparation was completed.
MATERIAL AND METHODS

Subject Selection
Colonoscopy
All patients were given verbal and written instructions to consume only clear liquids the day before colonoscopy, to drink half of the bowel preparation the night before colonoscopy and to complete the remainder of the preparation the morning of the procedure, aiming to nish 4 hours before the procedure was scheduled to begin. An oral sulfate solution (SUPREP®, Braintree Laboratories) was used by 92.9% of patients. ree gastroenterologists, each of whom had performed more than 10,000 colonoscopies, performed 54% (MV), 42% (RS) and 4% (KB) of the procedures. Colonoscopies performed by endoscopists MV and RS were preceded by administration of conscious sedation with a combination of midazolam and either fentanyl or meperidine. Diphenhydramine was administered as a 1-time dose of 50 mg for patient discomfort at the discretion of the endoscopist. All 18 procedures performed by endoscopist KB were performed using anesthesiologist-administered propofol. All procedures were performed using CF-160AL or CFH-180AL colonoscopes (Olympus Corporation). Biopsy specimens were submitted to our center's central processing unit and interpreted by one of the 9 sta pathologists.
Data Collection
We used an 18-item questionnaire designed speci cally for this study to collect data about the type and timing of bowel preparation, patient perception of bowel preparation and other information related to each patient's history (Supplementary Table I ). The endoscopists were aware of each patient's participation in the study but were blinded to the responses recorded in the questionnaire. Endoscopists were trained to use the Ottawa bowel preparation scale and report their assessment on a standardized form (Supplementary Table II) (http:www. jgld.ro/2014/2/supplementary-table-holt.doc). e Ottawa scale, which facilitates independent assessment of each colonic segment, has been extensively validated and is frequently used in bowel preparation studies (Table I) [11] [12] [13] Prior to the beginning of the study, each endoscopist completed a pre-test (6 images of the colon with varying-quality bowel preparation representing 2 sample colonoscopies), a training module (21 independent colonoscopic images) and a post-test (18 images representing 6 sample colonoscopies). Endoscopists were asked to assign an Ottawa score to each colonoscopic image. Inter-observer and intra-observer correlation for the participating endoscopists' scoring of posttest images was high (interclass correlation coe cient 0.94, p<0.0001; Cronbach's alpha 0.94, p=0.01). For all polyps, the colonic segment of origin, size, morphology and total number were recorded in the procedure report. All procedure reports and pathology reports were reviewed retrospectively by 2 of the investigators (EH and HM) and recorded in the study database. Polyp detection rate was de ned as the total number of patients with a polyp divided by the total number of patients in the designated group. An "excellent" or "good" bowel prep was de ned by an Ottawa score ≤4.
Statistical Analysis
The primary outcome was polyp detection and the secondary outcome was quality of bowel preparation. For each outcome the tolerability of bowel preparation was evaluated as an independent variable. Comparisons between groups were performed in univariate analysis using analysis of variance (ANOVA), Fisher's exact test or Student's t-test. Separate logistic regression analyses were performed to determine which independent variables predicted the primary outcome, polyp detection, and the secondary outcome, quality of bowel preparation. Odds ratios were mutually adjusted for all variables reported in each analysis. Statistical signi cance was de ned as p<0.05. All analyses were performed using SPSS (version 19; IBM, Armonk, NY) or STATA SE (version 12; StatCorp, College Station, TX).
RESULTS
Patients
Four hundred thirteen participants completed all parts of the questionnaire. Seventeen additional patients agreed to participate but did not complete the questionnaire and were not included in the analysis. e mean age was 60 ± 10 years, the mean BMI 26.0 ± 5.9 kg/m 2 and 49.2% of the patients were male; 66.8% of patients self-identi ed as Caucasian, 19.9% as Asian, 5.4% as Hispanic and 5.3% as African American; 75.5% of patients had a colonoscopy for screening or surveillance for polyps or cancer and 62.5% had previously had a colonoscopy. Additional clinical and demographic characteristics of patients are listed in Table II . P-values characterize di erences between "good" or "tolerable" and "unpleasant" or "intolerable"; 2 Other reasons for colonoscopy included abdominal pain, anemia, in ammatory bowel disease, diarrhea and removal of previously marked large polyp; 3 Withdrawal time includes time spent performing polypectomy.
Tolerability of Bowel Preparation
(consumption of <95% of the prep) compared to an unpleasant or intolerable rating, 2.9% vs. 17%, p<0.001. A more tolerable prep rating was not associated with a lower rate of self-reported solid material in the e uent compared to a less favorable rating, 2.6% vs. 6%, p=0.11.
A patient-reported unpleasant or intolerable experience with bowel preparation was signi cantly associated with female gender, prior abdominal surgery, longer colonoscopic insertion time, use of diphenhydramine during colonoscopy, lower quality bowel prep and lower polyp detection rate (Table II) . In a multivariate analysis, female gender independently increased the risk of an unpleasant or intolerable experience with bowel preparation by a factor of 3.93 (95% CI 2.30 -6.72, p<0.001).
Primary Outcome: Polyp Detection 56.4% of patients had at least one polyp, 29.3% had at least one right-sided polyp and 42.6% had at least one adenoma.
e PDR was higher in males than in females (65.2% vs. 48.1%, p<0.001). Polyp morphology was more frequently at (vs. sessile or pedunculated) in the right colon compared to the rectosigmoid: 16.5% vs. 6.4%, p=0.007. Polyp histology was more frequently adenomatous (including those with villous or serrated features) in the right colon compared to the rectosigmoid: 91% vs. 77.5%, p=0.02.
Polyp detection was signi cantly lower in patients who reported a less tolerable experience with bowel preparation (Table II) . Among those who rated the bowel preparation good or tolerable the PDR was 59.7%, including and 32.3% in the right colon, 20.8% in the mid colon and 37.4% in the rectosigmoid. Among those who rated the bowel preparation unpleasant or intolerable the PDR was 46%, including 20% in the right colon, 11% in the mid colon and 26% in the rectosigmoid (p<0.05 for each segmental comparison). We also determined that female gender is an independent risk factor for a poorly tolerated prep.
This is the first study we are aware of that separates tolerability from other patient-reported ratings of bowel preparation, and is also the rst to demonstrate its predictive role. Previous studies have evaluated the relationship between patient-rated quality of bowel preparation and endoscopistrated prep quality. In a cohort of 474 outpatients, Harewood et al found that patient-reported clarity of bowel preparation correlated poorly with endoscopist assessment, reporting a correlation coe cient of r=0.08 [8] . Fatima et al found a similarly poor correlation between patient and endoscopist rating of bowel preparation in a cohort of 429 outpatients, with Cohen's ĸ=0.067 [9] . In our similar-sized cohort, we replicated this poor correlation between patient and endoscopist rating of bowel prep, reporting a Cohen's ĸ=0. 15 . Unlike prior studies, however, we hypothesized that other measures of the patient's experience with bowel preparation may better identify those at risk for low-quality bowel prep, and that this risk might also apply to PDR.
Because patients do not have training or experience in evaluating the clarity of e uent a er bowel preparation, it is not surprising that they are poor predictors of the quality of their own prep. However, there is no standard against which to measure a patient's perception of the bowel preparation experience. e importance of the patient's experience with bowel preparation has been recognized in prior studies. In a recent systematic review, McLachlan et al reported that laxative bowel preparation remains the biggest barrier to screening colonoscopy, o en causing more discomfort than the procedure itself [14] . In another cross-sectional survey of patients undergoing outpatient colonoscopy, Sint Nicolaas et al found that female gender, age <50 years and 4L (vs. 2L) preparation were associated with a more burdensome experience [15] . In the present study we have replicated the nding that women are more likely to perceive bowel preparation as "unpleasant" or "intolerable" than men.
Female gender could act as a confounder between lower PDR and discomfort during bowel preparation because compared to men, women have lower rates of polyp detection and CRC mortality but higher rates of irritable bowel syndrome In a multivariate analysis age, gender, Ottawa score, duration of colonoscopy, withdrawal time and patient perception of the tolerability of bowel preparation were independently associated with detection of polyps (Table III) . ), interval from start of bowel prep to rst bowel movement, interval from end of bowel prep to beginning of colonoscopy, morning vs. a ernoon colonoscopy, patient-reported adherence (completeness) of bowel prep, patient reported clarity of e uent, patient-reported tolerability of bowel prep, history of polyps or cancer. Odds ratios were mutually adjusted for all variables reported in each analysis.
Patient-reported perception of bowel preparation as unpleasant or intolerable vs. good or tolerable was independently and inversely associated with polyp detection (OR 0.39, 95% CI 0.18 -0.84, p=0.017).
Secondary Outcome: Quality of Bowel Preparation
e mean endoscopist-reported Ottawa score was 2.4 ± 1.9 and 87.4% of patients had an excellent or good prep (Ottawa score ≤4). 96.6% of patients self-reported clear or yellow/ brown e uent without any solid particles at the end of bowel preparation. However, in a correlation analysis, agreement between patient-reported clarity of e uent and endoscopistreported Ottawa score was poor, with Cohen's kappa (ĸ) = 0.15 (p=0.001).
In a multivariate analysis, independent predictors of lower quality bowel preparation at colonoscopy (Ottawa score >4) included an interval between the beginning of the prep and the rst bowel movement of >2 hours, an interval between the end of bowel prep and the start of colonoscopy of >6 hours, self-reported e uent containing any solid material and selfreported unpleasant or intolerable experience with bowel preparation (Table IV) . Patient-reported perception of bowel preparation as unpleasant or intolerable vs. good or tolerable was independently associated with a lower quality bowel preparation (OR 2.39, 95% CI 1.17 -4.9, p=0.017).
DISCUSSION
In this cross-sectional cohort study we addressed a novel clinical question, namely whether a patient's perception of the tolerability of bowel preparation is associated with quality measures in colonoscopy. We found that a less tolerable experience with bowel preparation was inversely associated with both polyp detection and with bowel prep quality, measured by the validated Ottawa bowel preparation score. (IBS) [16] [17] [18] . Chey et al reported lower PDR in patients with IBS, even a er adjusting for age and gender, though the study was not designed to detect a di erence in polyp or adenoma yield and -unlike our study -did not account for di erences in indications for colonoscopy or a history of prior colonoscopy [19] . Others have reported an association between IBS and colonoscopic outcomes. Oh et al reported an association between IBS and colonoscopic insertion time, even if only female gender persisted as a risk factor for longer insertion time in a multivariate analysis [20] . We, too, examined insertion time and found it to be signi cantly longer in patients who reported a less tolerable experience with bowel preparation (Table II) .
We used PDR as our primary outcome rather than the more traditional quality measure, adenoma detection rate (ADR). From a biologic standpoint, ADR is more closely associated with risk of CRC than PDR. However, estimation of the PDR can be done with endoscopic data alone -independently of polyp histology -and can be calculated and tracked more easily by endoscopists.
ere is a growing body of evidence that PDR is a valid quality measure for colonoscopy. In a large retrospective cohort, Williams et al showed a high correlation between polyp detection and adenoma detection (r=0.91) [21] . e same correlation was reproduced in a more recent study by Gohel et al (r=0.8) , who found that the association was strongest for male patients and for polyps in the proximal colon [22] . erefore, we feel that the association between patient tolerability of bowel prep and PDR maintains important clinical implications for all gastroenterologists who perform colonoscopy.
Our novel ndings are strengthened by the reproduction of previously well-known associations. Male gender, older age and quality of bowel preparation were strong predictors of polyp detection in our study. e interval between bowel prep and colonoscopy, a more recently-established predictor of bowel prep quality, was independently associated with Ottawa score [13] . Prior abdominal surgery and insertion time have also been reported as variables a ecting quality outcomes in colonoscopy, as they were in our study [23, 24] . An additional variable that merits further investigation is the interval between initiation of bowel preparation and rst bowel movement, which we found to be an independent predictor of bowel prep quality. As is now the case with many of these variables, if the predictive capability of prep tolerability is replicated it would become an important clinical indicator. Patients who perceive the prep as intolerable may present a technical challenge to endoscopists and may be at risk for both low quality bowel preparation and for missed polyps.
Our study has several limitations. Our patient questionnaire, developed for this study, has not been validated. e Ottawa scores in our study were lower than in other studies that have used this scale, though this did not prevent us from identifying independent predictors of bowel prep quality [12, 13] . We did not collect certain elements of medical history, sociodemographic history or biologic data that would have given insight into a potential mechanism behind our ndings. Additionally, the potential clinical benefit of alerting the colonoscopist about a poorly tolerated prep was not tested and thus remains theoretical. While we feel that PDR is a valid measure of quality outcomes in colonoscopy, our study was underpowered to demonstrate that patient tolerability of bowel preparation also predicted ADR. Lastly, we reported odds ratios for our logistic regression analyses even though the high frequency of polyp detection does not meet the 'rare disease assumption' , which could have exaggerated the relative risk of our primary and secondary outcomes. Despite this possibility we feel our results are clinically signi cant, particularly in light of the fact that other known predictors of quality outcomes in colonoscopy were reproduced in this study (Table III) .
ere are a number of reasons a patient may tolerate a bowel preparation poorly, including taste, inconvenience, compliance and physical discomfort. We chose to study the patient tolerability of bowel preparation because there is a general paucity of research on patient-related variables in colonoscopic research. Our ndings are broad but strongly suggest a relationship between how the patient perceives the bowel preparation and what occurs during colonoscopy. Our results merit further investigation in larger, prospective studies. Such studies should identify more speci cally what the patient found intolerable and propose changes to the bowel prep that might improve prep quality. Ideally, future studies would also identify procedural modi cations that could improve the yield of colonoscopy in these patients, such as the use of more sedation or a deliberately slower insertion time.
CONCLUSIONS
We found that patient-perceived tolerability of bowel preparation is independently associated with polyp detection and with the quality of bowel preparation. We also found that female gender is an independent risk factor for a poorly tolerated prep. We propose that a poorly tolerated bowel prep may foreshadow both a lower quality bowel preparation and a technically di cult colonoscopy, marked by a longer insertion time, need for additional sedation and a higher risk for missed polyps. We emphasize the hypothetical nature of this proposal, and hope that future studies will elucidate the mechanism linking tolerability of bowel preparation to quality outcomes. Such work would facilitate the development of focused interventions, improve the yield of screening colonoscopy and further strengthen our ability to prevent colorectal cancer.
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